CalhounDA, MurthySN, BryantBG, LuedtkeSA, Bhatt-MehtaV.Recent advances in neonatal pharmacotherapy. Ann Pharmacother2006;40:710–9. Epub 28 March 2006. DOI 10.1345/aph.1G212
2.
MoscaF, MilenaB, StucchiI, FumagalliM.Pulmonary hypertension after ibuprofen prophylaxis in very preterm infants. Lancet2002;360:1023–4.
3.
GournayV, SavagnerC, ThiriezG, KusterA, RozeJC. Pulmonary hypertension after ibuprofen prophylaxis in very preterm infants. Lancet2002;359:1486–8.
4.
GournayV, RozeJC, KuserA.Prophylactic ibuprofen versus placebo in very premature infants: a randomized, double-blind, placebo-controlled trial. Lancet2004;364:1939–44.
5.
ArandaJV, ThomasR.Intravenous ibuprofen for preterm newborns. Neoreviews2005;6:c516–22.
6.
BelliniC, CamponeF, SerraG.Pulmonary hypertension following L-lysine ibuprofen therapy in a preterm infant with patent ductus arteriosus. CMAJ2006;174:1843–4.
7.
OhlssonA, WaliaR, ShahS.Ibuprofen for the treatment of patent ductus arteriosus in preterm and/or low birth weight infants. The Cochrane Database of Systematic Reviews 2005, issue 4. art. no. Cochrane Database Syst Rev2005(4): CD003481. pub2. DOI 10.1002/14651858.CD003481.pub2
